48 related articles for article (PubMed ID: 30957730)
1. Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries.
Oortwijn W; van Oosterhout S; Kapiriri L
Int J Technol Assess Health Care; 2020 Jul; ():1-5. PubMed ID: 32715993
[TBL] [Abstract][Full Text] [Related]
2. Fair Processes for Priority Setting: Putting Theory into Practice Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
Jansen MP; Helderman JK; Boer B; Baltussen R
Int J Health Policy Manag; 2017 Jan; 6(1):43-47. PubMed ID: 28005541
[TBL] [Abstract][Full Text] [Related]
3. Principles for deliberative processes in health technology assessment.
Bond K; Stiffell R; Ollendorf DA
Int J Technol Assess Health Care; 2020 Aug; ():1-8. PubMed ID: 32746954
[TBL] [Abstract][Full Text] [Related]
4. Expanded HTA: Enhancing Fairness and Legitimacy.
Daniels N; Porteny T; Urritia J
Int J Health Policy Manag; 2015 Nov; 5(1):1-3. PubMed ID: 26673643
[TBL] [Abstract][Full Text] [Related]
5. The Use of Evidence-Informed Deliberative Processes for Health Insurance Benefit Package Revision in Iran.
Nouhi M; Baltussen R; Razavi SS; Bijlmakers L; Sahraian MA; Goudarzi Z; Farokhian P; Khedmati J; Jahangiri R; Olyaeemanesh A
Int J Health Policy Manag; 2022 Dec; 11(11):2719-2726. PubMed ID: 35247943
[TBL] [Abstract][Full Text] [Related]
6. Harnessing Country Experiences for Health Benefit Package Design: Evidence-Informed Deliberative Processes and Experiences From the Joint Learning Network Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
Nagpal S; Ahluwalia N; Hashiguchi LO; McGee K; Lutalo M
Int J Health Policy Manag; 2023; 12():7856. PubMed ID: 38618786
[TBL] [Abstract][Full Text] [Related]
7. The Need for Global Application of the Accountability for Reasonableness Approach to Support Sustainable Outcomes Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
Byskov J; Maluka SO; Marchal B; Shayo EH; Bukachi S; Zulu OM; Blas E; Michelo C; Ndawi B; Hurtig AK
Int J Health Policy Manag; 2017 Feb; 6(2):115-118. PubMed ID: 28812788
[TBL] [Abstract][Full Text] [Related]
8. The judgement process in evidence-based medicine and health technology assessment.
Kelly MP; Moore TA
Soc Theory Health; 2012 Feb; 10(1):1-19. PubMed ID: 23226973
[TBL] [Abstract][Full Text] [Related]
9. Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know.
Latimer NR; Rutherford MJ
Pharmacoeconomics; 2024 Jul; ():. PubMed ID: 38967908
[TBL] [Abstract][Full Text] [Related]
10. Implicit factors influencing the HTA deliberative processes in 5 European countries: results from a mixed-methods research.
Monleón C; Martin-Späth H; Crespo C; Dussart C; Toumi M
Health Policy Open; 2023 Dec; 5():100109. PubMed ID: 38073709
[TBL] [Abstract][Full Text] [Related]
11. Moving towards social inclusion: Engaging rural voices in priority setting for health.
Tugendhaft A; Christofides N; Stacey N; Kahn K; Erzse A; Danis M; Gold M; Hofman K
Health Expect; 2023 Oct; 27(1):. PubMed ID: 37882224
[TBL] [Abstract][Full Text] [Related]
12. Systematic literature review on the implicit factors influencing the HTA deliberative process in Europe.
Monleón C; Späth HM; Crespo C; Dussart C; Toumi M
J Mark Access Health Policy; 2022; 10(1):2094047. PubMed ID: 35811835
[TBL] [Abstract][Full Text] [Related]
13. Integrating health technology assessment and the right to health: a qualitative content analysis of procedural values in South African judicial decisions.
DiStefano MJ; Abdool Karim S; Krubiner CB
Health Policy Plan; 2022 May; 37(5):644-654. PubMed ID: 34792599
[TBL] [Abstract][Full Text] [Related]
14. Addressing Health System Values in Health Technology Assessment: The Use of Evidence-Informed Deliberative Processes.
Oortwijn W; Klein P
Int J Technol Assess Health Care; 2019; 35(2):82-84. PubMed ID: 30957730
[TBL] [Abstract][Full Text] [Related]
15. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design - Part I: Conceptual Framework.
Baltussen R; Jansen M; Oortwijn W
Int J Health Policy Manag; 2022 Oct; 11(10):2319-2326. PubMed ID: 34923808
[TBL] [Abstract][Full Text] [Related]
16. Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
Oortwijn W; Jansen M; Baltussen R
Int J Health Policy Manag; 2020 Jan; 9(1):27-33. PubMed ID: 31902192
[TBL] [Abstract][Full Text] [Related]
17. Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes.
Baltussen R; Jansen MPM; Bijlmakers L; Grutters J; Kluytmans A; Reuzel RP; Tummers M; der Wilt GJV
Value Health; 2017 Feb; 20(2):256-260. PubMed ID: 28237205
[TBL] [Abstract][Full Text] [Related]
18. Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide.
Oortwijn W; Jansen M; Baltussen R
Int J Health Policy Manag; 2022 Oct; 11(10):2327-2336. PubMed ID: 34923809
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
